Latest News for: mmv
Edit
Malaria Drug Discovery: Hit-to-Lead Research Collaboration with MMV Targeting a Novel Therapeutic Target Molecule (Daiichi Sankyo Co Ltd)
Public Technologies 27 Apr 2026
) Daiichi Sankyo has entered into a collaborative research agreement with Medicines for Malaria Venture (MMV) to conduct hit-to-lead research aimed at identifying inhibitors of PfPFN (Plasmodium ...
Edit
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
PR Newswire 22 Apr 2026
This project is being led by Medicines for Malaria Venture (MMV), Tanabe Pharma Corporation in Japan, and the University of Georgia in the United States ... Hit-to-Lead project for an antimalarial drug led by MMV and DAIICHI SANKYO COMPANY, LIMITED.
- 1